CRM
Salesforce, Inc.
AI Software — Enterprise CRM / Agentic Workflow
~$179 ⚠
Mkt Cap ~$146B
52W: $163.52 – $296.05
Next earnings: 2026-05-27 (AMC)
✚ Strong Add
Entry zone: $160–$205
The market is pricing CRM as a legacy SaaS vendor in AI-driven secular decline at EV/FCF of 10.9× — yet 29,000 Agentforce production deals with $800M ARR (+169% YoY) represent confirmed monetization, not a demo cycle. Salesforce's data moat (200K+ enterprise customers with years of clean CRM data) is the foundational asset for agent deployment that no AI-native competitor can replicate at scale, and the consumption-plus-seat model expands the monetizable surface of the installed base rather than disrupting it.
TTM P/E
23.3×
GAAP
Fwd P/E
13.6×
non-GAAP · PEG 0.86
Rev YoY
+12%
Q4 FY26 (accel)
Gross Margin
77.7%
FY26 TTM
FCF Margin
34.7%
$14.4B FCF
EV / FCF
10.9×
Rule of 40: 45
Thesis Durability
B+
Variant perception: Market treats AI as an existential threat to CRM seat revenue; reality is consumption pricing turns every agentic action across Salesforce's existing 200K+ customer base into incremental ARR.
TAM: $11B CRM AI market growing >30% annually (multiple analyst sources ⚠). Salesforce commands 21% of total CRM market share vs. Microsoft at 6% — a 3× lead with structural switching-cost protection.
AI revenue concreteness: Agentforce ARR $800M (+169% YoY);1 Agentforce + Data 360 ARR $2.9B (+200%);1 29,000 deals closed; 2.4B Agentic Work Units delivered. This is revenue in the income statement, not pipeline.
Moat: Enterprise CRM migration cost is prohibitively high; 70%+ of top-100 Q4 wins included 5+ clouds — multi-cloud depth creates an exit cost moat that compounds over time.1
Bear case: Microsoft Dynamics + Copilot Studio bundles undercut on price for Microsoft-native enterprises; AI-native startups compete at the SME/mid-market layer. Organic growth without Informatica is ~7–8% in FY27 — modest for a premium multiple. Not fatal, but caps the rerating.
TAM: $11B CRM AI market growing >30% annually (multiple analyst sources ⚠). Salesforce commands 21% of total CRM market share vs. Microsoft at 6% — a 3× lead with structural switching-cost protection.
AI revenue concreteness: Agentforce ARR $800M (+169% YoY);1 Agentforce + Data 360 ARR $2.9B (+200%);1 29,000 deals closed; 2.4B Agentic Work Units delivered. This is revenue in the income statement, not pipeline.
Moat: Enterprise CRM migration cost is prohibitively high; 70%+ of top-100 Q4 wins included 5+ clouds — multi-cloud depth creates an exit cost moat that compounds over time.1
Bear case: Microsoft Dynamics + Copilot Studio bundles undercut on price for Microsoft-native enterprises; AI-native startups compete at the SME/mid-market layer. Organic growth without Informatica is ~7–8% in FY27 — modest for a premium multiple. Not fatal, but caps the rerating.
Sound thesis with one unproven element. Monetization is real; organic re-acceleration (guided for H2 FY27) is the outstanding proof point. Dim 1 is B+, not A, because the growth rate without Informatica has not yet demonstrated the re-acceleration management is guiding.
Business Quality
A−
Margins (FY26): Gross 77.7%, non-GAAP operating 34.1% (FY27 guided 34.3% — expanding). GAAP operating 20.1%, held down by SBC and intangibles amortization.1
FCF: $14.4B (+16% YoY), FCF margin 34.7%. Operating cash flow $15.0B (+15%). EV/FCF 10.9× — historically cheap for this quality of cash generation.2
Capital returns: $50B share buyback authorized (new); quarterly dividend raised 5.8% YoY to $0.44/share. $14.3B returned to shareholders in FY26.1
⚠ SBC caveat: Stock-based compensation is ~$4.2B/year (~9.0% of FY27 revenue). This bridges most of the GAAP/non-GAAP EPS gap ($7.89 GAAP vs. $13.15 non-GAAP). Real economic dilution — the forward P/E of 13.6× is non-GAAP; GAAP fwd P/E is ~22.7×.
⚠ NRR not disclosed: Salesforce stopped reporting NRR explicitly — a visibility gap for the primary SaaS quality metric.
Insider Form 4 (last 90 days): Director Laura Alber made open-market purchases of 2,571 shares at $194.54 in March 2026 — the only open-market buy in the 90-day window, a mildly positive signal. CEO Benioff holds 11.9M shares directly; C-suite received new performance options at $280.62 exercise price (56% above current price) — management compensation highly at-risk at current levels, aligning incentives with shareholders.3 No open-market insider selling found.
FCF: $14.4B (+16% YoY), FCF margin 34.7%. Operating cash flow $15.0B (+15%). EV/FCF 10.9× — historically cheap for this quality of cash generation.2
Capital returns: $50B share buyback authorized (new); quarterly dividend raised 5.8% YoY to $0.44/share. $14.3B returned to shareholders in FY26.1
⚠ SBC caveat: Stock-based compensation is ~$4.2B/year (~9.0% of FY27 revenue). This bridges most of the GAAP/non-GAAP EPS gap ($7.89 GAAP vs. $13.15 non-GAAP). Real economic dilution — the forward P/E of 13.6× is non-GAAP; GAAP fwd P/E is ~22.7×.
⚠ NRR not disclosed: Salesforce stopped reporting NRR explicitly — a visibility gap for the primary SaaS quality metric.
Insider Form 4 (last 90 days): Director Laura Alber made open-market purchases of 2,571 shares at $194.54 in March 2026 — the only open-market buy in the 90-day window, a mildly positive signal. CEO Benioff holds 11.9M shares directly; C-suite received new performance options at $280.62 exercise price (56% above current price) — management compensation highly at-risk at current levels, aligning incentives with shareholders.3 No open-market insider selling found.
Solid with two caveats. FCF quality is excellent; SBC dilution (~$4.2B/year) and the absence of NRR reporting are the structural watch items. The 56%-underwater executive options reinforce alignment.
Entry Price Discipline
A
Valuation snapshot:
vs. software peers: Software industry fwd P/E ~18–30×; ServiceNow trades ~30–35×, MSFT ~28×, ADBE ~17×. CRM's 13.6× non-GAAP is the cheapest in large-cap enterprise SaaS.
Latest quarter: Q4 FY26 — revenue $11.2B (+12%), non-GAAP EPS $3.81 (beat).1 cRPO +16% YoY is the highest in FY26 — a leading indicator of future revenue.
My variant view on EPS path: Consensus assumes ~10–11% revenue growth in FY27. I believe Agentforce consumption revenue will outperform consensus in H2 FY27 as production deployments scale. If Agentforce ARR continues at even 80% of its current trajectory, it adds $1B+ incremental ARR by FY27 end, pulling organic growth toward 10%+ ex-Informatica.
Short interest: 9.06% of float (just below the 10% flag threshold).2 Approaching squeeze territory if sentiment inflects.
Distance from entry zone: Current price ~$179 is within $160–$205 zone. Well inside entry — not above it.
- Fwd non-GAAP P/E: 13.6× (FY27 $13.15 guide)
- Fwd GAAP P/E: 22.7× (FY27 $7.89 guide)
- EV/FCF: 10.9×; PEG: 0.86; EV/EBITDA: 12.5×
vs. software peers: Software industry fwd P/E ~18–30×; ServiceNow trades ~30–35×, MSFT ~28×, ADBE ~17×. CRM's 13.6× non-GAAP is the cheapest in large-cap enterprise SaaS.
Latest quarter: Q4 FY26 — revenue $11.2B (+12%), non-GAAP EPS $3.81 (beat).1 cRPO +16% YoY is the highest in FY26 — a leading indicator of future revenue.
My variant view on EPS path: Consensus assumes ~10–11% revenue growth in FY27. I believe Agentforce consumption revenue will outperform consensus in H2 FY27 as production deployments scale. If Agentforce ARR continues at even 80% of its current trajectory, it adds $1B+ incremental ARR by FY27 end, pulling organic growth toward 10%+ ex-Informatica.
Short interest: 9.06% of float (just below the 10% flag threshold).2 Approaching squeeze territory if sentiment inflects.
Distance from entry zone: Current price ~$179 is within $160–$205 zone. Well inside entry — not above it.
At entry zone. Current price below both DCF scenarios (bear ~$274, bull ~$401); EV/FCF 10.9× prices CRM as a no-growth utility. Significant margin of safety even on conservative assumptions.
✚ Strong Add — New Position
CRM sits at a rare confluence: confirmed AI monetization (not just narrative), an established enterprise data moat, pristine FCF ($14.4B, +16%), and a multiple (EV/FCF 10.9×, fwd non-GAAP P/E 13.6×) that prices in permanent growth compression. The DCF bear case — using SBC-adjusted FCF at 30% deceleration — yields ~$274 fair value, 53% above the current price. Q1 FY27 earnings on 27 May (in 14 days) are the nearest catalyst: watch for organic growth ex-Informatica, Agentforce ARR trajectory, and management's H2 re-acceleration confidence.
Do not add above $225 (above this level, the entry premium erodes the margin of safety relative to the H2 reacceleration promise). If Q1 FY27 confirms organic growth ≥8% ex-Informatica, scale to full medium-conviction position.
Do not add above $225 (above this level, the entry premium erodes the margin of safety relative to the H2 reacceleration promise). If Q1 FY27 confirms organic growth ≥8% ex-Informatica, scale to full medium-conviction position.
Size to 6% of total portfolio as a starter. Scale to 10% if Q1 FY27 confirms organic re-acceleration. Hard cap: 20%. (Active picks currently ~29.4% vs ~50% target — capacity exists.)
Opportunity-cost check
▾
vs CSPX
CRM's DCF bear case implies 53% upside vs. CSPX's ~8–10% expected CAGR; EV/FCF 10.9× at confirmed 10%+ revenue growth offers an asymmetric setup that passive beta cannot replicate.
vs current holdings
CRM adds an AI Software — Enterprise Workflow layer not covered by existing positions. PLTR covers gov/commercial data AI; GOOGL covers hyperscaler AI; CRM covers enterprise agentic workflow. Doesn't stack MAGS. Sits alongside NOW (enterprise SaaS) as a second AI-software position but with a different thesis driver (Agentforce monetization vs. NOW's Iran derate recovery).
Thesis-breakers
▾
- 01 Agentforce ARR growth rate drops below 50% YoY in any quarter through Q4 FY27 — signals monetization plateau has arrived before organic re-acceleration could materially absorb seat-based headwinds.
- 02 Organic revenue growth (ex-Informatica ~3pts contribution) decelerates below 6% for two consecutive quarters in H1 FY27 — confirms the Agentforce lift is not sufficient to offset legacy seat compression and the re-acceleration narrative collapses.
- 03 Non-GAAP operating margin contracts more than 1pp from FY26's 34.1% by FY27 Q2 print — signals AI token cost absorption is permanently compressing profitability rather than resolving toward neutral as guided.
Key risks
▾
- 01 Microsoft bundling: Dynamics 365 + Copilot Studio is sold at a bundle discount to Microsoft 365 enterprises. If Microsoft captures 2–4% CRM market share points over 3 years, that costs Salesforce ~$1–2B in ARR at current ASPs — a 5–10% revenue headwind concentrated in the most profitable enterprise tier.
- 02 Informatica integration risk: The $8B acquisition closes with ~$17.7B total gross debt on the balance sheet; net debt position is -$8.1B. Integration of a complex data-management platform while simultaneously scaling Agentforce stretches management bandwidth. The 3pts FY27 contribution could mask organic deceleration for 2–3 quarters before visibility clarifies.
- 03 Agentforce gross margin dilution: Token costs are currently dilutive to overall company margins; management has guided for neutral AI gross margins "near term" without a specific timeline.5 If LLM token costs don't compress on the expected curve, the consumption model could compress overall non-GAAP margins from 34.1% toward 32–33% — eroding the quality of earnings growth.
- 04 SBC dilution drag: $4.2B/year in SBC (~9% of revenue) is permanent economic dilution. The share count has fallen -1.85% in 12 months — buybacks are absorbing it, but if FCF growth slows, the $50B buyback authorization is harder to deploy at this rate, and SBC net-dilution could re-emerge.
- 05 NRR opacity: Salesforce stopped disclosing NRR — the primary quality metric for enterprise SaaS expansion revenue. Without this, it's impossible to independently verify whether Agentforce ARR is incremental or a rebundle of existing contracts. This is a thesis-quality risk, not just a reporting preference.
DCF scenarios
▾
Discount rate: 11% — Large-cap profitable SaaS; slightly above MSFT/AAPL band (9–10%) to account for ~$4.2B annual SBC dilution risk and Informatica integration execution risk. FCF base year: FY26 ($14.40B reported). Note: these use reported (unadjusted) FCF; if SBC-adjusted FCF of ~$10.2B is used as base, fair values are lower by ~$115–130/share.
5Y FCF CAGR
12%
Terminal growth
5%
Fair value / share
~$401
vs current
+124%
Agentforce consumption ARR scales to ~$3B by FY29; organic revenue re-accelerates to 11%+ in H2 FY27 as guided; non-GAAP margin expands to 36%+ by FY29. FCF path: $16.1B → $18.0B → $20.2B → $22.6B → $25.3B. Terminal value at Year 5 discounted at 11%: ~$263B. Sum of PV cash flows ~$74B. Total equity value ~$328B; per share (818M shares): ~$401.
5Y FCF CAGR
8.4%
Terminal growth
3%
Fair value / share
~$274
vs current
+53%
30% immediate growth deceleration from FY27 guide: FCF CAGR compresses to 8.4%. Agentforce monetization plateaus; organic growth stays 6–7%; token margins don't improve. Lower terminal growth (3%) reflects mature SaaS positioning. FCF path: $15.6B → $16.9B → $18.3B → $19.9B → $21.6B. Terminal at Year 5 (3% g, 11% discount): ~$452B → PV ~$268B. Total equity ~$224B; per share: ~$274.
Position: Current price (~$179) is below both scenarios — priced at a substantial discount even to the conservative bear case. The market is implying either permanent FCF decline or a much higher discount rate (>16%), neither of which is supported by FY26 fundamentals.
Catalyst timeline
▾
-
2026-05-27Q1 FY27 earnings (AMC) — most important near-term print. Watch: (1) organic growth ex-Informatica, (2) Agentforce ARR QoQ trajectory, (3) non-GAAP margin vs. 34.1% FY26 base, (4) H2 FY27 re-acceleration guidance reaffirmed or trimmed. A clean beat + reaffirm on these metrics would catalyse a re-rating from 13.6× toward 18–20× non-GAAP fwd P/E.
-
2026-Q3Agentforce gross margin commentary — management guided AI gross margins to "neutral near term." Any explicit quarter where Agentforce turns margin-neutral would remove a core bear concern and expand the multiple.
-
2026-Q3/Q4H2 FY27 organic growth re-acceleration — the thesis confirmation event. If Q2 and Q3 FY27 (Oct/Dec 2026 reports) show organic revenue growth ≥9%, the narrative shifts from "legacy SaaS defense" to "AI monetization compounder" and the multiple re-rates meaningfully.
-
2026-ongoingNew FY27 disaggregated revenue reporting — Salesforce announced updated revenue segmentation for FY27. Clearer AI ARR vs. legacy ARR disclosure removes the "is Agentforce incremental?" ambiguity and is a structural positive for the multiple.
Named analyst commentary
▾
No coverage from tracked analysts (Serenity/@aleabitoreddit, Beth Kindig/IO Fund, Dylan Patel/SemiAnalysis). All three focus primarily on semiconductor infrastructure; neither has published direct CRM analysis. Web search conducted 2026-05-13 — no relevant commentary found.
Sources
1 Salesforce Q4 FY26 earnings press release (8-K Exhibit 99.1) — SEC EDGAR, filed 2026-02-25 · edgar.sec.gov
2 Stockanalysis.com — Statistics/Valuation page, accessed 2026-05-13
3 StockTitan.net — Form 4 insider filings, accessed 2026-05-13 ⚠ open-market purchases only; RSU vesting/withholding excluded from signal assessment
4 public.com/FinanceCharts.com — Historical P/E data, accessed 2026-05-13
5 Medium/Blossom Street Ventures — Q4 FY26 SaaS earnings round-up, March 2026 · Salesforce AI gross margin commentary
⚠ = figure not verifiable from open-access sources or sourced from a single provider. Current stock price (~$179) is estimated from 7 May–11 data; use live feed before executing. TAM figure ($11B CRM AI market) sourced from ainvest.com — treat as directional only.
1 Salesforce Q4 FY26 earnings press release (8-K Exhibit 99.1) — SEC EDGAR, filed 2026-02-25 · edgar.sec.gov
2 Stockanalysis.com — Statistics/Valuation page, accessed 2026-05-13
3 StockTitan.net — Form 4 insider filings, accessed 2026-05-13 ⚠ open-market purchases only; RSU vesting/withholding excluded from signal assessment
4 public.com/FinanceCharts.com — Historical P/E data, accessed 2026-05-13
5 Medium/Blossom Street Ventures — Q4 FY26 SaaS earnings round-up, March 2026 · Salesforce AI gross margin commentary
⚠ = figure not verifiable from open-access sources or sourced from a single provider. Current stock price (~$179) is estimated from 7 May–11 data; use live feed before executing. TAM figure ($11B CRM AI market) sourced from ainvest.com — treat as directional only.